Aaron James Laurita - 18 Mar 2026 Form 3 Insider Report for Radiopharm Theranostics Ltd (RADX)

Reporting relationship
Chief Financial Officer
Issuer ticker
RADX
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
30 Apr 2026, 21:51:42 UTC
Prior SEC filing
29 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron James Laurita

Key filing fact

Aaron James Laurita filed Form 3 for Radiopharm Theranostics Ltd (RADX) on 30 Apr 2026.

Key facts

  • This page summarizes Aaron James Laurita's Form 3 filing for Radiopharm Theranostics Ltd (RADX).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Apr 2026, 21:51.

Change

  • Previous filing in this sequence was filed on 29 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002125949 Primary reporting owner

Laurita Aaron James

Relationship
Chief Financial Officer
Address
SUITE 1 LEVEL 3, 62 LYGON STREET, CARLTON SOUTH, VICTORIA, AUSTRALIA
Signature
/s/ Aaron James Laurita
Signature date
30 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RADX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,357
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RADX holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
17,857
Exercise price
$0.2000
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

All exercise prices are in Australian dollars.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .